Efficacy and safety of IL-6 inhibitors in patients with COVID-19 pneumonia: a systematic review and meta-analysis of multicentre, randomized trials.
Alessandro BellettiCorrado CampochiaroMarilena MarmiereValery LikhvantsevAndrey YavorovskiyLorenzo DagnaGiovanni LandoniAlberto ZangrilloLudhmila Abrahão HajjarPublished in: Annals of intensive care (2021)
IL-6 inhibitors reduced longest follow-up mortality and intubation in COVID-19 patients. Findings need to be confirmed in high-quality RCTs.